Advances in organ-specific cancer research have significantly enhanced our understanding of cancer's unique biology and progression within different organs. Researchers are now focusing on how cancer cells behave differently in various tissues, which has led to more targeted therapies and personalized treatment plans. For instance, breakthroughs in breast cancer research have highlighted the role of specific genetic mutations in tumor development, allowing for therapies that target those mutations. Similarly, liver cancer research has uncovered the role of the liver's microenvironment in cancer growth, paving the way for treatments that disrupt these interactions. Advances in imaging technologies and biomarker identification have also allowed for earlier detection, improving prognosis and treatment outcomes. With ongoing progress in molecular profiling and organ-specific models, these advances are paving the way for more effective, tailored therapies, offering hope for improved survival rates across multiple cancer types.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India